Shindo T, Maehana T, Tanaka T, Hashimoto K, et al. Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study. Int J Urol 2022 Jun 2. doi: 10.1111/iju.14941.
PMID: 35654444